{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:07:33Z","timestamp":1778274453418,"version":"3.51.4"},"reference-count":19,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"vor","delay-in-days":4346,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Toxicology"],"published-print":{"date-parts":[[1997,5]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Bisphosphonates are used clinically to inhibit bone resorption but they may also cause renal damage. For the profiling of new, potent bisphosphonates, their adverse renal effects were investigated in 2 rat models. In the first model, bisphosphonate was repeatedly injected (1 mg\/kg, subcutaneously) over 2 weeks and the urinary excretion of malate dehydrogenase was monitored to assess nephrotoxic potential. Of the 6 new compounds tested, 3 markedly elevated malate dehydrogenase whereas 3 others caused only minor changes similar to those observed with 6 reference bisphosphonates that are already used clinically. On the basis of a therapeutic index (inhibition of bone resorption versus renal effects) 7\u2010180 fold greater than that of other analogues, the compound CGP 42446 was further profiled. In the second model, CGP 42446 or pamidronate was infused (1.5\u201050 mg\/kg, intravenously) into anaesthetized rats and the serum urea concentration was monitored as an indicator of renal dysfunction. Both compounds elevated serum urea in a time\u2010and dose\u2010dependent manner, but the ED<jats:sub>100<\/jats:sub> value for CGP 42446 was 3.8\u2010fold higher than that of pamidronate. It is concluded that CGP 42446 (zoledronate) has a low nephrotoxic potential and can be further developed as a new, potent inhibitor of bone resorption.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1997.tb01964.x","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T18:24:49Z","timestamp":1238005489000},"page":"225-230","source":"Crossref","is-referenced-by-count":68,"title":["Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short\u2010Term Rat Models"],"prefix":"10.1111","volume":"80","author":[{"given":"Jonathan R.","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Seltenmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut A.","family":"Jaeggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Widler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/01926233890171P104"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/01926233900184P204"},{"key":"e_1_2_1_4_1","first-page":"265","article-title":"Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives","volume":"54","author":"Bisaz S.","year":"1978","journal-title":"Clin. Sci. Mol. Med."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91465-4"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-6009(91)90131-I"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00334615"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199141020-00009"},{"key":"e_1_2_1_9_1","volume-title":"Bisphosphonates in bone disease: from the laboratory to the patient.","author":"Fleisch H.","year":"1995"},{"key":"e_1_2_1_10_1","first-page":"672","article-title":"Polynuclear complex formation in solutions of calcium ion and ethane\u20101\u2010hydroxy\u20101,1\u2010diphosphonic acid. I. Complexometric and pH titrations","volume":"75","author":"Grabenstetter R. J.","year":"1971","journal-title":"J. Phys. Chem."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090521"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92434-0"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90488-8"},{"key":"e_1_2_1_14_1","first-page":"107","article-title":"Tolerability and safety of clodronate therapy in bone diseases","volume":"11","author":"Mian M.","year":"1991","journal-title":"Int. J. Clin. Pharm. Res."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02196199"},{"issue":"1","key":"e_1_2_1_16_1","first-page":"S373","article-title":"A double blind placebo\u2010controlled trial using intravenous zoledronate (CGP 42446) in patients with Paget's disease of bone","volume":"11","author":"Schaffer A. V.","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1975.70"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/j100675a013"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92253-6"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00334614"}],"container-title":["Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1997.tb01964.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1997.tb01964.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:51:37Z","timestamp":1698407497000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1997.tb01964.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["10.1111\/j.1600-0773.1997.tb01964.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1997.tb01964.x","archive":["Portico"],"relation":{},"ISSN":["0901-9928"],"issn-type":[{"value":"0901-9928","type":"print"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}